Pancreatic Neuroendocrine Tumor - 24 Studies Found

Active, not recruiting : Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors
:
  • Neuroendocrine Tumors
  • Gastro Entero Pancreatic Neuroendocrine Tumors : 2016-04-07
    :
    • Drug: 28 GBq 177Lu-DOTATATE Pa
Recruiting : Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors
:
  • Advanced Renal Cell Carcinoma
  • Gastrointestinal Stromal Tumors
  • Neuroendocrine Tumor
  • Carcinoid Tumor
  • : 2009-12-01
    : Drug: AMG 479 Given intravenously once every three weeks
RECRUITING : Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the Liver
: Pancreatic Neuroendocrine Tumor
: 2024-12-04
: Cytoreductive surgery is an operation to remove as much tumor tissue as possible.
<<< Previous